What we're reading, April 27, 2016: Hawaii passes bill to protect transgender patients; childhood obesity has plateaued, not declined; and HHS awards $5 million to Puerto Rico to fight the Zika virus.
Hawaii has taken a different approach to transgender patients compared with Mississippi and Tennessee. The Hawaii Legislature has passed a bill that prohibits insurance companies from discriminating against transgender patients by denying, canceling, or limiting coverage based on the person’s gender identity, reported The Washington Post. The bill has already passed the state senate and is now going to the governor. One of the bill’s opponents expressed concern that it could mandate coverage of gender reassignment surgery, which would be costly for everyone.
Despite optimistic reports, there hasn’t been a decline in childhood obesity. However, NPR reported that the prevalence of obesity among US children has plateaued. From 1999 to 2014 there was a consistent increase in obesity. But there have been success stories and promising efforts placing more attention on preventing obesity among primary care physicians and pediatricians may lead to some declines, according to researchers.
While Congress has yet to approve the requested funding to combat the Zika virus, HHS awarded $5 million to Puerto Rico to fight the spread of the virus. The money will go to 20 health centers to use to expand voluntary family planning services, outreach, education, and to hire more staff, according to a press release. So far 474 cases of Zika in Puerto Rico have been reported and the number is expected to continue rising.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More